期刊文献+

芳香化酶抑制剂在妇科内分泌治疗中的应用效果观察 被引量:14

Effect observation of aromatase inhibitors application in gynecological endocrine
下载PDF
导出
摘要 目的探讨芳香化酶抑制剂在妇科内分泌治疗中的应用效果。方法选取本院2009年8月~2012年10月收治的74例妇科内分泌患者,针对所有患者的临床资料及实际情况进行分析,并对患者采用芳香化酶抑制剂进行治疗,主要包括依西美坦、阿那曲唑及来曲唑,评估患者的治疗效果。结果 74例患者中,基本治愈39例,显效21例,好转9例,无效5例,治疗总有效率为93.2%;无效的5例患者主要是由于其心理因素影响,与医护人员的配合度不高所致。结论临床上应用芳香化酶抑制剂治疗妇科内分泌疾病的效果较为显著,对于促进患者病情的改善及生活质量提高具有重要意义,值得在临床推广应用。 Objective To investigate the effects of aromatase inhibitors in gynecological endocrine therapy.Methods Seventy four cases of patients with gynecological endocrinology in our hospital were treated between August 2009 to October 2012,the clinical data and the actual situation of all patients were analyzed,and treated with aromatase in- hibitors for treatment,including exemestane,anastrozole to letrozole,outcomes of patient was evaluated.Results Seventy four patients,basic cured 39 cases,21 cases were markedly,improved in 9 cases,5 cases were ineffective,the total effec- tive rate was 93.2%;invalid patients was due to psychological factors,with the medical staff with due.Conclusion Clini- cal application of aromatase inhibitors to treat gynecological endocrine diseases with more obvious,is of great significan- ce for promoting the improvement of the patient's condition and to improve the quality of life,worthy of clinical application.
作者 李秀萍
出处 《中国当代医药》 2013年第20期41-42,共2页 China Modern Medicine
关键词 妇科内分泌 芳香化酶抑制剂 应用效果 Gynecological endocrine Aromatase inhibitors Application efficacy
  • 相关文献

参考文献10

二级参考文献119

  • 1彭超,周应芳.子宫腺肌症318例诊治分析[J].中国妇产科临床杂志,2001,2(2):72-74. 被引量:45
  • 2赵珊琼,丁慧青,赵伟红.子宫内膜异位症术后辅助用药疗效分析[J].浙江临床医学,2004,3(11):988-989. 被引量:1
  • 3郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:278
  • 4刘晓瑛,李宝艳,周维,周丽萍,陈云峰.腹腔镜手术加用 GnRH-A 治疗子宫内膜异位症[J].中国临床医学,2005,12(5):941-941. 被引量:17
  • 5Kudoh M, Susaki Y, Ideyama Y, et al. Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor- I gene expression in rats with experimental endometriosis. J Steroid Biochem Mol Biol, 1997, 63(1-3):75-80.
  • 6Yano S ,Ikegami Y, Nakao K, et al .Studies on the effect of the new non-steroidal aromatase inhibitor fadrozole hydrochloride in an endometriosis model in rats. Arzneimittelforschung,1996, 46(2): 192-5.
  • 7Thiantanawat A, Long B J, Brodie AM, et al. Singaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens. Cancer Res, 2003, 63(22): 8 037-50.
  • 8Sasano H, Sato S, Ito K, et al. Effects of aromatase inhibitors on the pathobiology of the human breast,endometrial and ovarian carcinoma. Endocr Relat Cancer, 1999, 6(2): 197-204.
  • 9Bulun SE, Zeitoun K, Takayama K, et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endo Rel Cancer, 1999, 6(2):293-301.
  • 10Leahy KM, Omberg RL, Wang Y, et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res,2002, 62(3): 625-31.

共引文献32

同被引文献93

引证文献14

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部